Zilart 125 mg tablete za oralnu suspenziju
| Name | Zilart 125 mg tablete za oralnu suspenziju |
|---|---|
| Marketing Authorisation Number | HR-H-474588710 |
| Active Substance | deferasiroks |
| Composition | svaka tableta za oralnu suspenziju sadrži 125 mg deferasiroksa |
| Pharmaceutical Form | tableta za oralnu suspenziju |
| Manufacturer | Pharmascience International Limited, Nicosia, Cipar |
| Marketing Authorisation Holder | Makpharm d.o.o., Trnjanska cesta 37/1, Zagreb, Hrvatska |
| Marketing Authorisation Date | 31.05.2023 |
| MA Period of Validity | unlimited |
| Classification Number | UP/I-530-09/22-02/122 |
| Registration Number | 381-12-01/154-23-11 |
| Prescription | Medicinal product subject to medical prescription |
| Type of prescription | ograničeni recept |
| Distribution | Supply through pharmacies (community) |
| Advertising to general public | not allowed |
| ATC Code | V03AC03 |
| Marketing status | stavljeno u promet |
| Shortage status | nema nestašice |
| SmPC | download |
| PL | download |
| Public Assessment Report | preuzmi |
| Educational materials for healthcare professionals |
Brošura za zdravstvene radnike, verzija 1 |
| Educational materials for patients / caregivers |
Brošura za bolesnike, verzija 1 |
